Researchers are studying the gut resistome to better understand antimicrobial resistance biology and its implications for clinical risk. Various approaches, including metagenomic analysis and next-generation sequencing, are being used to profile antimicrobial resistance in different contexts, such as the gut microbiota of various species and in wastewater. The studies aim to inform our understanding of the complex relationships between the microbiome, antibiotic resistance, and disease.